What happened: Ayush Suraksha portal and regulatory push against misleading Ayush drug ads
The Ministry of AYUSH strengthened monitoring and action against misleading and objectionable advertisements for Ayush drugs. The Ministry launched the IT-enabled online portal “Ayush Suraksha” in 2025 to track reported Misleading Advertisements (MLAs)/Objectionable Advertisements (OAs) and Adverse Drug Reactions (ADRs), and reported the complaint inflow and selected state actions.
Background and earlier position: Pharmacovigilance for Ayush drugs since 2018 and integration under AOGUSY
The Ministry implemented the Pharmacovigilance Programme for Ayush drugs since 2018 to monitor safety of Ayush medicines through surveillance, reporting, and assessment of suspected adverse drug reactions, and to monitor misleading advertisements to prevent false and exaggerated claims.
What changed now: complaint counts, online tracking, and coordinated enforcement ecosystem
Related current affairs
- Ministry of AYUSH launches initiatives to promote production, quality, research and global acceptance of AYUSH medicines
- Maharashtra allows homeopathic doctors to give alternative medicine orders after a bridge course
- Maharashtra allows homeopathy doctors to give affordable medicine after bridge course; critics question the policy
- Homeopaths allowed to prescribe modern drugs after bridge course; critics question rationale
- IPC signs/renews MoUs with DSMNRU and CSIR-CIMAP to advance healthcare quality and innovation
- Digital market access and quality assurance measures for AYUSH drugs